In a triple-negative breast cancer cell line (MDA-MB-231), but not in an estrogen receptor (ER)-positive cell line (MCF-7), 2-DG was able to reduce glucose uptake (Table 1) [65]. Here, ESR1 is linked to triple-negative breast carcinoma.